Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema

Ocular Immunology and Inflammation

Volumn 13, Issue 2-3, 2005, Pages 205-212

  Androudi, Sofia ^b   Letko, Erik ^b   Meniconi, Margherita ^b   Papadaki, Thekla ^b   Ahmed, Muna ^b   Foster, C Stephen ^a  

^a Massachusetts Eye Research and Surgery Institute   (United States)

^b NONE

Author keywords

Macular edema; Triamcinolone acetonide; Uveitis

Indexed keywords

TRIAMCINOLONE ACETONIDE; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CATARACT; CLINICAL ARTICLE; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GLAUCOMA DRAINAGE IMPLANT; HUMAN; INTRAOCULAR PRESSURE; MALE; RECURRENT DISEASE; RELAPSE; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; COMPARATIVE STUDY; INJECTION; MIDDLE AGED; PATHOPHYSIOLOGY; SAFETY; VITREOUS BODY;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SAFETY; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; UVEITIS; VISUAL ACUITY; VITREOUS BODY;

EID: 25144459643     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940590933511     Document Type: Article

References (43)

1. Rothova A, Suttorp-Van Schulten MS, Treffers W, et al. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80:332-336.
2. Fine HF, Baffi J, Reed GF, et al. Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema. Am J Ophthalmol. 2001;132:794-796.
3. Freeman G. Cystoid macular edema in uveitis: an unsolved problem. Eye. 2001;15:12-17.
4. Nussenblatt RB. Macular alterations secondary to intraocular inflammatory disease. Ophthalmology. 1986;93:984-988.
5. Lafranco Dafflon M, Tran XT, Guex-Crosier Y, Herbert CP. Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects. Graefes Arch Clin Exp Ophthalmol. 1999;237:289-295.
6. Trash AB, Dugel PU, Flindall RJ, et al. A comparison of retrobulbar versus sub-Tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications. Ophthalmology. 1997;104:2003-2008.
7. Cox SN, Hay E, Bird AC. Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol. 1988;106:1190-1195.
8. Farber MD, Lam S, Tessler HH. Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomized prospective crossover study. Br J Ophthalmol. 1994;78:4-7.
9. Whitcup SM, Csaky KG, Podgor MJ. A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis. Ophthalmology. 1996;103:1054-1063.
10. Zierhut M, Thiel HJ, Schlote T. Treatment of uveitic macular edema with acetazolamide. Doc Ophthalmol. 1999;97:409-413.
11. Aylward GW. The place of vitreoretinal surgery in the treatment of macular oedema. Doc Ophthalmol. 1999;97:433-438.
12. Diamond JG, Kaplan HJ. Lensectomy and vitrectomy for complicated cataract secondary to uveitis. Arch Ophthalmol. 1978;96:1798-1804.
13. Dugel P, Rao N, Ozler S, et al. Pars plana vitrectomy for intraocular inflammation-related cystoid macular edema unresponsive to corticosteroids. Ophthalmology. 1992;99:1535-1541.
14. Wiechens B, Nolle B, Reichelt JA. Pars-plana vitrectomy in cystoid macular edema associated with intermediate uveitis. Graefes Arch Clin Exp Ophthalmol. 2001;239:474-481.
15. Helm CJ, Holland GN. The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol. 1995;120:55-64.
16. Ip MS, Kumar KS. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol. 2002;120:1217-1219.
17. Jonas JB, Kreissig I, Soefker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic maculae edema. Arch Ophthalmol. 2003;121:57-61.
18. Jonas JB, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol. 2001;132:425-427.
19. Martidis A, Duker DJ, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 2002;109:920-927.
20. Conway MD, Canakis C, Livir-Rallatos C, Peyman GA. Intravitreal triamcinolone for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg. 2003;29:27-33.
21. Antcliff RJ, Spalton DJ, Stanford MR. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology. 2001;108:765-772.
22. Young S, Larkin G, Branley M, et al. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol. 2001;29:2-6.
23. Ferris FL, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94:91-96.
24. Chylack LT, Leske MC, McCarty D, et al. Lens opacities classification system II. Arch Ophthalmol. 1989;107:991-997.
25. Hida T, Chandler D, Arena JE, Machemer R. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol. 1986;101:190-195.
26. McCuen 2nd BW, Bessler M, Tano Y, et al. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol. 1981;91:785-820.
27. Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol. 1980;90:810-816.
28. Weiss JF, Belkin M. Glucocorticosteroid inhibition of intraocular proliferation. Am J Ophthalmol. 1981;92:133.
29. Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina. 2000;20:244-250.
30. Ghalla JK, Gillies MC, Penfold PL, et al. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow-up. Aust NZ Ophthalmol. 1998;26:277-281.
31. Jonas JB, Hayler JK, Sofker A, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol. 2001;131:468-471.
32. Jonas JB, Hayler JK, Panda-Jonas S. Intravitreal injection of crystalline cortisone as treatment of pre-phthisical ocular hypotony. Graefes Arch Clin Exp Ophthalmol. 2001;239:464-465.
33. Jonas JB, Hayler JK, Sofker A, Panda-Jonas S. Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone. J Glaucoma. 2001;10:284-287.
34. Sakamoto T, Miyazaki M, Hisatomi T, et al. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol. 2002;240:423-429.
35. Schindler RH, Chandler D, Thresher R, Machemer R. The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol. 1982;93:415-417.
36. Schohes GN, O'Brien WJ, Abrams GW, Kubicek MF. Clearance of triamcinolone from vitreous. Arch Ophthalmol. 1985;103:1567-1569.
37. Kwak HW, D'Amico DJ. Evaluation of retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection. Arch Ophthalmol. 1992;110:259-266.
38. Beer PM, Bakri SJ, Singh RJ, et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology. 2003;110:681-686.
39. Wingate RJ, Beaumont PE. Intravitreal triamcinolone and elevated intraocular pressure. Aust NZ Ophthalmol. 1999;27:431-432.
40. Reid DM, Hughes RA, Laan RF, et al. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-induced Osteoporosis Treatment Study. J Bone Miner Res. 2000;15:1006-1013.
41. Mitchell P, Cumming RG, Mackey DA. Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology. 1999;106:2301-2306.
42. Williamson J, Paterson RW, McGavin DM, et al. Posterior subcapsular cataracts and glaucoma associated with long-term oral corticosteroid therapy. Br J Ophthalmol. 1969;53:361-372.
43. Schubert HD. Cystoid macular edema: the apparent role of mechanical factors. Prog Clin Biol Res. 1989;312:277-291.